India is launching cheap, weight-loss drugs and Novo Nordisk is betting on its brands to stay on top
Indian generic drugmakers launch a price war against Novo Nordisk’s GLP-1 brands, Ozempic and WeGovy.
India is launching cheap, weight-loss drugs and Novo Nordisk is betting on its brands to stay on top
Indian generic drugmakers launch a price war against Novo Nordisk’s GLP-1 brands, Ozempic and WeGovy.
FilterCNBC
Clustered coverageCNBC
Coverage timeline1
Coverage timeline
Coverage timeline
Ranked reports inside the event cluster. Open any publisher link to read the original coverage.
Related events
Related events
Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.
1 report1 sourceSimilarity 0.27
US weight-loss drugmakers slash prices in fight to win customers
Weight-loss drug prices are falling in the US - but can the example be repeated?
BBC News
1 report1 sourceSimilarity 0.24
US-Israeli war on Iran strains food, water and fuel prices in India
Locals in northern India have a growing concern over costs of essential resources due to the Iran war.
Al Jazeera
1 report1 sourceSimilarity 0.21
India news: We can withstand Middle East turmoil, Modi tells parliament
PM Narendra Modi said the Iran war is straining supply chains and trade routes, but stressed India's economic fundamentals remain strong.
DW
1 report1 sourceSimilarity 0.21
GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up
For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses.
CNBC
1 report1 sourceSimilarity 0.12
Kyle Sandilands launches legal action over $100m contract termination
Controversial radio host Kyle Sandilands has launched legal action against ARN Media after it terminated his $100 million contract.
ABC Australia
1 report1 sourceSimilarity 0.11
Walmart digital price labels are coming to every store shelf in U.S. by end of 2026
Walmart is rolling out digital shelf labels and expects it to be in all U.S. stores by year’s end. Is it surge pricing in disguise or just new tech efficiency?
CNBC